Abdulrahman Abonofal

机构：East Tennessee State University, West Virginia University · ORCID：0000-0001-5534-4888

发表论文 16 篇 · 总被引 324 次 · h-index 7

代表论文

Phase 2 study of pembrolizumab in patients with advanced rare cancers (2020 · Journal for ImmunoTherapy of Cancer · 被引 131)
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract (2020 · Gynecologic Oncology · 被引 72)
Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial (2022 · Journal for ImmunoTherapy of Cancer · 被引 46)
A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma (2023 · Cancers · 被引 25)
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial (2021 · Investigational New Drugs · 被引 25)
NSAIDs do not reduce severity among post-ERCP pancreatitis patients (2023 · Pancreatology · 被引 9)